Skip to main content

Biostage, Inc. (BSTG)

OTCMKTS: BSTG · IEX Real-Time Price · USD
3.00 -0.05 (-1.64%)
Oct 26, 2021 11:24 AM EDT - Market closed

Company Description

Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology.

The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea.

The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.

Biostage, Inc.
Biostage Logo
CountryUnited States
SectorHealth Care

Contact Details

84 October Hill Road
Holliston, MA 01746
United States
Phone774 233 7300

Stock Details

Ticker SymbolBSTG
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001563665
CUSIP Number09074M103
ISIN NumberUS09074M2026
Employer ID45-5210462

Key Executives

Yu HongPresident
Dr. William L. Fodor Ph.D.Chief Scientific Officer
Peter A. Pellegrino Jr.Interim Vice President of Finance
Dr. Shunfu Hu Ph.D.Vice President of Business Development and Operations